Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID‐19 Pandemic (Arthritis Care & Research, 2024)

(untitled) - Mercadé‐Besora, N; Guo, Y; Du, M; Li, X; Ramírez‐Anguita, JM; Moreno, A; Valente, A; Villalobos, F; Cheng, IL; Carrasco‐Ribelles, LA; van Swieten, MMH; Merkelbach, M; et al.